222 related articles for article (PubMed ID: 19574417)
21. Overdiagnosis in cancer.
Welch HG; Black WC
J Natl Cancer Inst; 2010 May; 102(9):605-13. PubMed ID: 20413742
[TBL] [Abstract][Full Text] [Related]
22. Analysis of serum cancer procoagulant activity and its possible use as a tumor marker.
Gordon SG; Benson B
Thromb Res; 1989 Nov; 56(3):431-40. PubMed ID: 2617480
[TBL] [Abstract][Full Text] [Related]
23. Unleashing the power of proteomics to develop blood-based cancer markers.
Taguchi A; Hanash SM
Clin Chem; 2013 Jan; 59(1):119-26. PubMed ID: 23099557
[TBL] [Abstract][Full Text] [Related]
24. Anti-malignin antibody evaluation: a possible challenge for cancer management.
Botti C; Martinetti A; Nerini-Molteni S; Ferrari L
Int J Biol Markers; 1997; 12(4):141-7. PubMed ID: 9582602
[TBL] [Abstract][Full Text] [Related]
25. [Clinical use of D-dimer in patients with cancer].
Lecumberri R; Pegenaute C; Páramo JA
Med Clin (Barc); 2011 Oct; 137(10):453-8. PubMed ID: 21074815
[TBL] [Abstract][Full Text] [Related]
26. The future of blood-based biomarkers for the early detection of breast cancer.
Loke SY; Lee ASG
Eur J Cancer; 2018 Mar; 92():54-68. PubMed ID: 29413690
[TBL] [Abstract][Full Text] [Related]
27. Blood markers for early detection of colorectal cancer: a systematic review.
Hundt S; Haug U; Brenner H
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1935-53. PubMed ID: 17932341
[TBL] [Abstract][Full Text] [Related]
28. [Early cancer diagnosis through proteomics of serum: fiction or fact?].
Zapico Muñiz E; Mora Brugés J; Blanco Vaca F
Med Clin (Barc); 2005 Feb; 124(5):181-5. PubMed ID: 15725370
[No Abstract] [Full Text] [Related]
29. Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting.
Chen H; Werner S; Butt J; Zörnig I; Knebel P; Michel A; Eichmüller SB; Jäger D; Waterboer T; Pawlita M; Brenner H
Oncotarget; 2016 Mar; 7(13):16420-32. PubMed ID: 26909861
[TBL] [Abstract][Full Text] [Related]
30. A blood-based biomarker panel for stratifying current risk for colorectal cancer.
Marshall KW; Mohr S; Khettabi FE; Nossova N; Chao S; Bao W; Ma J; Li XJ; Liew CC
Int J Cancer; 2010 Mar; 126(5):1177-86. PubMed ID: 19795455
[TBL] [Abstract][Full Text] [Related]
31. Risk Algorithm Using Serial Biomarker Measurements Doubles the Number of Screen-Detected Cancers Compared With a Single-Threshold Rule in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.
Menon U; Ryan A; Kalsi J; Gentry-Maharaj A; Dawnay A; Habib M; Apostolidou S; Singh N; Benjamin E; Burnell M; Davies S; Sharma A; Gunu R; Godfrey K; Lopes A; Oram D; Herod J; Williamson K; Seif MW; Jenkins H; Mould T; Woolas R; Murdoch JB; Dobbs S; Amso NN; Leeson S; Cruickshank D; Scott I; Fallowfield L; Widschwendter M; Reynolds K; McGuire A; Campbell S; Parmar M; Skates SJ; Jacobs I
J Clin Oncol; 2015 Jun; 33(18):2062-71. PubMed ID: 25964255
[TBL] [Abstract][Full Text] [Related]
32. A novel mixed integer programming for multi-biomarker panel identification by distinguishing malignant from benign colorectal tumors.
Zou M; Zhang PJ; Wen XY; Chen L; Tian YP; Wang Y
Methods; 2015 Jul; 83():3-17. PubMed ID: 25980368
[TBL] [Abstract][Full Text] [Related]
33. Distribution of IgG galactosylation as a promising biomarker for cancer screening in multiple cancer types.
Ren S; Zhang Z; Xu C; Guo L; Lu R; Sun Y; Guo J; Qin R; Qin W; Gu J
Cell Res; 2016 Aug; 26(8):963-6. PubMed ID: 27364686
[No Abstract] [Full Text] [Related]
34. Multimodal lung cancer screening using the ITALUNG biomarker panel and low dose computed tomography. Results of the ITALUNG biomarker study.
Carozzi FM; Bisanzi S; Carrozzi L; Falaschi F; Lopes Pegna A; Mascalchi M; Picozzi G; Peluso M; Sani C; Greco L; Ocello C; Paci E;
Int J Cancer; 2017 Jul; 141(1):94-101. PubMed ID: 28387927
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein α-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags.
Sogawa K; Takano S; Iida F; Satoh M; Tsuchida S; Kawashima Y; Yoshitomi H; Sanda A; Kodera Y; Takizawa H; Mikata R; Ohtsuka M; Shimizu H; Miyazaki M; Yokosuka O; Nomura F
Br J Cancer; 2016 Oct; 115(8):949-956. PubMed ID: 27657339
[TBL] [Abstract][Full Text] [Related]
36. Validation: a critical step in bringing biomarkers to clinical fruition.
Srivastava S; Kramer BS
Ann Epidemiol; 2018 Feb; 28(2):135-138. PubMed ID: 29157735
[TBL] [Abstract][Full Text] [Related]
37. Comparing adaptive and non-adaptive algorithms for cancer early detection with novel biomarkers.
Sato AH; Anderson GL; Urban N; McIntosh MW
Cancer Biomark; 2006; 2(3-4):151-62. PubMed ID: 17192068
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic Devices for Circulating Biomarkers Detection and Quantification.
Bedin C; Crotti S; Tasciotti E; Agostini M
Curr Med Chem; 2018; 25(34):4304-4327. PubMed ID: 29149830
[TBL] [Abstract][Full Text] [Related]
39. Multiplex quantitation of 270 plasma protein markers to identify a signature for early detection of colorectal cancer.
Bhardwaj M; Weigl K; Tikk K; Holland-Letz T; Schrotz-King P; Borchers CH; Brenner H
Eur J Cancer; 2020 Mar; 127():30-40. PubMed ID: 31972396
[TBL] [Abstract][Full Text] [Related]
40. Clinical application of tumour markers: a review.
Amayo AA; Kuria JG
East Afr Med J; 2009 Dec; 86(12 Suppl):S76-83. PubMed ID: 21591514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
